Dose effect and duration of action of liposomal bupivacaine administered as a perineural analgesic in a reversible and adjustable frog-pressure model of equine lameness.

The research article is about an experiment that studied the effects of liposomal bupivacaine, an analgesic drug, in horses with induced lameness. The variable factors were the dosage and how long it lasted.

Objective and Methodology

• The purpose of the study was to investigate the dose effect and the duration of action of liposomal bupivacaine (LB) — a drug typically used for local anesthesia and pain relief, delivered via peri-neural injection — in a model of equine lameness. A model of equine lameness is a state of handicap induced intentionally in the horse’s forelimb for this experiment. The method used to induce lameness involved applying pressure on the horse’s lower leg, specifically the frog (a part of a horse’s foot).
• Twelve clinically healthy adult horses were used for the trial, with one of their limbs subjected to saline and the other to LB. Balancing for potential bias, this study design allowed each horse to serve as its own control, comparing the effects of LB against saline. The doses of LB were divided into low doses and high doses.

Experiment and Analysis

• After lameness was induced in one forelimb of each horse, peri-neural injection of the lower horse leg nerves was performed using either saline (as a control), a low dose of LB (0.25 mg/kg), or a high-dose of LB (0.5 mg/kg). The order of these treatments was random and there was a one-week period between each to eliminate potential carry-on effects.
• Various types of data were collected before and after the administration of the LB including distal limb swelling, mechanical nociceptive thresholds (MNT – a measure of pain response), and objective lameness data.
• The collected data were analyzed using different statistical methods. The changes in MNT and lameness over time were compared to the baseline measurements. The researchers also compared the median duration of analgesia and time taken for lameness to return between the low dose and high dose groups.

Results and Conclusion

• Both low-dose and high-dose LB resulted in loss of skin sensation and an observed improvement in lameness. However, there was significant variability among horses in terms of how long the effect of the drug lasted.
• For the low-dose LB group, the median duration of the analgesic effect was approximately 4.5 hours, with lameness returning in a median of 7 hours. For the high-dose group, the median duration of analgesia was around 12 hours, with lameness returning at around the 9-hour mark.
• An adverse effect noted was that mild to moderate swelling occurred in 92% of the limbs treated with LB. This might be indicative of a possible side effect associated with LB administration.